Scientifically Rigorous Real-World Evidence Strategy
As randomized controlled trials take center stage during clinical development, implementing a scientifically rigorous real-world evidence strategy will help put your product in the best position for regulatory and reimbursement success. Our experts are well-versed in using proven methods for collecting and analyzing retrospective and prospective data. Working in collaboration with our health economics and market access researchers, we can provide you with a roadmap to help ensure your evidence aligns and demonstrates the full value of your product.
We can help you:
- Conduct SLR and MTC
- Evaluate unmet need, burden of illness, treatment patterns and costs
- Engage patient directly through qualitative interviews, focus groups and social media analyses
- Conduct early payer engagement to support future coverage decisions that support economic value and quality-of-life benefits
- Develop or evaluate clinical outcomes assessment measurement strategy
- Develop endpoint model
- Begin development of GVD and AMCP dossier
- Evaluate adherence/persistence of SOC and future comparators
- Develop and finalize core cost-effectiveness model (local economic model development)
- Develop and finalize budget-impact model
- Develop market access and communication plan
- Develop RWD/RWE strategy and tactical plan
- Develop communication/publication plan
- Value message confirmation
Image
